Cwm, LLC Erasca, Inc. Transaction History

Cwm, LLC

$24.1 Billion
Q4 2024

A detailed history of Cwm, LLC transactions in Erasca, Inc. stock. As of the latest transaction made, Cwm, LLC holds 1,806 shares of ERAS stock, worth $3,214. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,806

Previous 1,839 1.79%

Holding current value

$3,214

Previous $5,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	SELL	$2.44 - $3.23 $80 - $106	-33 Reduced 1.79%	1,806 $5,000
Q3 2024 Oct 08, 2024	BUY	$2.17 - $3.28 $2,285 - $3,453	1,053 Added 133.97%	1,839 $5,000
Q2 2024 Jul 09, 2024	BUY	$1.79 - $2.63 $844 - $1,241	472 Added 150.32%	786 $2,000
Q1 2024 Apr 05, 2024	SELL	$1.67 - $2.55 $85 - $130	-51 Reduced 13.97%	314 $1,000
Q4 2023 Feb 01, 2024	SELL	$1.67 - $2.49 $387 - $577	-232 Reduced 38.86%	365 $1,000
Q3 2023 Oct 11, 2023	BUY	$1.97 - $2.91 $1,105 - $1,632	561 Added 1558.33%	597 $1,000
Q2 2023 Aug 03, 2023	BUY	$2.57 - $3.3 $92 - $118	36 New	36 $0

Others Institutions Holding ERAS

# of Institutions

141

Shares Held

229M

Call Options Held

28.7K

Put Options Held

117K

View Full List

About Erasca, Inc.

Ticker ERAS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 122,147,000
Market Cap $217M
Description
Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...

More about ERAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account